|
1
|
Nyska A, Shemesh M, Tal H and Dayan D:
Gingival hyperplasia induced by calcium channel blockers: Mode of
action. Med Hypotheses. 43:115–118. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lafzi A, Farahani RM and Shoja MA:
Amlodipine-induced gingival hyperplasia. Med Oral Patol Oral Cir
Bucal. 11:E480–E482. 2006.PubMed/NCBI
|
|
3
|
Joshi S and Bansal S: A rare case report
of amlodipine-induced gingival enlargement and review of its
pathogenesis. Case Rep Dent. 2013:1382482013.PubMed/NCBI
|
|
4
|
Fay AA, Satheesh K and Gapski R:
Felodipine-influenced gingival enlargement in an uncontrolled type
2 diabetic patient. J Periodontol. 76:12172005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sucu M, Yuce M and Davutoglu V:
Amlodipine-induced massive gingival hypertrophy. Can Fam Physician.
57:436–437. 2011.PubMed/NCBI
|
|
6
|
Hallmon WW and Rossmann JA: The role of
drugs in the pathogenesis of gingival overgrowth. A collective
review of current concepts. Periodontol 2000. 21:176–196. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seymour RA, Thomason JM and Ellis JS: The
pathogenesis of drug-induced gingival overgrowth. J Clin
Periodontol. 23:165–175. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ono M, Tanaka S, Takeuchi R, Matsumoto H,
Okada H, Yamamoto H, Makiyama Y, Hirayama T, Sakamaki T, Fujii A
and Akimoto Y: Prevalence of Amlodipine-induced Gingival
Overgrowth. Int J Oral-Med Sci. 9:96–100. 2010. View Article : Google Scholar
|
|
9
|
Hassell TM and Gilbert GH: Phenytoin
sensitivity of fibroblasts as the basis for susceptibility to
gingival enlargement. Am J Pathol. 112:218–223. 1983.PubMed/NCBI
|
|
10
|
Casetta I, Granieri E, Desiderá M, Monetti
VC, Tola MR, Paolino E, Govoni V and Calura G: Phenytoin-induced
gingival overgrowth: A community-based cross-sectional study in
Ferrara, Italy. Neuroepidemiology. 16:296–303. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Brunsvold M, Tomasovic J and Ruemping D:
The measured effect of phenytoin withdrawal on gingival hyperplasia
in children. ASDC J Dent Child. 52:417–421. 1985.PubMed/NCBI
|
|
12
|
Rateitschak-Plüss EM, Hefti A, Lörtscher R
and Thiel G: Initial observation that cyclosporin-A induces
gingival enlargement in man. J Clin Periodontol. 10:237–246. 1983.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pisanty S, Rahamim E, Ben-Ezra D and
Shoshan S: Prolonged systemic administration of cyclosporin A
affects gingival epithelium. J Periodontol. 61:138–141. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Daly CG: Resolution of cyclosporin A
(CsA)-induced gingival enlargement following reduction in CsA
dosage. J Clin Periodontol. 19:143–145. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Barak S, Engelberg IS and Hiss J: Gingival
hyperplasia caused by nifedipine. Histopathologic findings. J
Periodontol. 58:639–642. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romanos GE, Schröter-Kermani C, Hinz N,
Herrmann D, Strub JR and Bernimoulin JP: Extracellular matrix
analysis of nifedipine-induced gingival overgrowth:
Immunohistochemical distribution of different collagen types as
well as the glycoprotein fibronectin. J Periodontal Res. 28:10–16.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miranda J, Brunet L, Roset P, Berini L,
Farré M and Mendieta C: Prevalence and risk of gingival enlargement
in patients treated with nifedipine. J Periodontol. 72:605–611.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pernu HE, Oikarinen K, Hietanen J and
Knuuttila M: Verapamil-induced gingival overgrowth: A clinical,
histologic, and biochemic approach. J Oral Pathol Med. 18:422–425.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miller CS and Damm DD: Incidence of
verapamil-induced gingival hyperplasia in a dental population. J
Periodontol. 63:453–456. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mehta AV, Chidambaram B and O'Riordan AC:
Verapamil-induced gingival hyperplasia in children. Am Heart J.
124:535–536. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Giustiniani S, Robustelli della Cuna F and
Marieni M: Hyperplastic gingivitis during diltiazem therapy. Int J
Cardiol. 15:247–249. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fattore L, Stablein M, Bredfeldt G, Semla
T, Moran M and Doherty-Greenberg JM: Gingival hyperplasia: A side
effect of nifedipine and diltiazem. Spec Care Dentist. 11:107–109.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Godfraind T: Calcium channel blockers in
cardiovascular pharmacotherapy. J Cardiovasc Pharmacol Ther.
19:501–515. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Godfraind T: Mechanisms of action of
calcium entry blockers. Fed Proc. 40:2866–2871. 1981.PubMed/NCBI
|
|
25
|
Soward AL, Vanhaleweyk GL and Serruys PW:
The haemodynamic effects of nifedipine, verapamil and diltiazem in
patients with coronary artery disease. A review. Drugs. 32:66–101.
1986. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bose T, Cieślar-Pobuda A and Wiechec E:
Role of ion channels in regulating Ca2+ homeostasis
during the interplay between immune and cancer cells. Cell Death
Dis. 6:e16482015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lombardi T, Fiore-Donno G, Belser U and Di
Felice R: Felodipine-induced gingival hyperplasia: A clinical and
histologic study. J Oral Pathol Med. 20:89–92. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thomas P, Tolstoy R and Duraisingh L:
Amlodipine induced gingival hyperplasia: A case report. Int J Basic
Clin Pharmacol. 805–807. 2015.(In Chinese). View Article : Google Scholar
|
|
29
|
Gong Y, Lu J, Ding X and Yu Y: Effect of
adjunctive roxithromycin therapy on interleukin-1β, transforming
growth factor-β1 and vascular endothelial growth factor in gingival
crevicular fluid of cyclosporine A-treated patients with gingival
overgrowth. J Periodontal Res. 49:448–457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Matsumoto H, Takeuchi R, Ono M, Akimoto Y,
Kobayashi N and Fujii A: Drug-induced gingival overgrowth and its
tentative pharmacotherapy. Jpn Dent Sci Rev. 46:11–16. 2010.
View Article : Google Scholar
|
|
31
|
Van Dis ML, Allen CM and Neville BW:
Erythematous gingival enlargement in diabetic patients: A report of
four cases. J Oral Maxillofac Surg. 46:794–798. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Padmanabhan S and Dwarakanath CD: Severe
gingival enlargement associated with aggressive periodontitis. J
Indian Soc Periodontol. 17:115–119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Agrawal AA: Gingival enlargements:
Differential diagnosis and review of literature. World J Clin
Cases. 3:779–788. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Reali L, Zuliani E, Gabutti L, Schönholzer
C and Marone C: Poor oral hygiene enhances gingival overgrowth
caused by calcineurin inhibitors. J Clin Pharm Ther. 34:255–260.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Khzam N, Bailey D, Yie HS and Bakr MM:
Gingival enlargement induced by felodipine resolves with a
conventional periodontal treatment and drug modification. Case Rep
Dent. 2016:10959272016.PubMed/NCBI
|
